Romania: Pharmaceutical producer Antibiotice to benefit from EIB guidance on strengthening corporate governance and investment capacity

This article is published in association with European Investment Bank.This article is published in association with European Investment Bank. The European Investment Bank (EIB) will advise Antibiotice SA, the largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations […]
Go back up

The European Sting – Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology – europeansting.com